Mineralys Therapeutics, Inc. Stock (MLYS)
Track Mineralys Therapeutics, Inc. stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
MLYS
Mineralys Therapeutics, Inc.
healthcare
$31.29
▲ +14.28 (+90.78%) past year
Market Cap
$2.47B
P/E Ratio
—
1Y Return
+90.78%
EPS (TTM)
-$2.06
Read the latest TheStreet Pro articles mentioning Mineralys Therapeutics, Inc., including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning MLYS yet.
Daily Diary Mentions
0 mentionsNo diary mentions for MLYS yet.